At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
In Brief
A Phase 4 clinical trial evaluating Tranexamic Acid for Subdural Hematoma. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This is a single center single arm study of 50 patients to 1) determine the safety of tranexamic acid in the chronic subdural hematoma population following surgical drainage of chronic subdural hematomas and 2) determine if the use of oral tranexamic acid reduces the rate of ipsilateral recurrence following drainage of chronic subdural hematomas. This will be compared to historical controls. This study intends to be a prerequisite to a large nationally funded randomized control trial.
Study Details
Timeline
Interventions
1300mg tranexamic acid by mouth once before surgery and then three times a day for up to three days or until they are discharged from the hospital, whichever comes first